Abstract. X-linked Alport syndrome (XLAS) is a progressive disorder of basement membranes caused by mutations in the COL4A5 gene, encoding the ␣5 chain of type IV collagen. A mouse model of this disorder was generated by targeting a human nonsense mutation, G5X, to the mouse Col4a5 gene. As predicted for a nonsense mutation, hemizygous mutant male mice are null and heterozygous carrier female mice are mosaic for ␣5(IV) chain expression. Mutant male mice and carrier female mice are viable through reproductive age and fertile. Mutant male mice died spontaneously at 6 to 34 wk of age, and carrier female mice died at 8 to 45 wk of age, manifesting proteinuria, azotemia, and progressive and manifold histologic abnormalities of the kidney glomerulus and tubulointerstitium. Ultrastructural abnormalities of the glomerular basement membrane, including lamellation and splitting, were characteristic of human XLAS. The mouse model described here recapitulates essential clinical and pathologic findings of human XLAS. With ␣5(IV) expression reflecting X-inactivation patterns, it will be especially useful in studying determinants of disease variability in the carrier state.
predicted to convert codon 5 from glycine to a stop codon (G5X), has been described in a 15-yr-old boy who exhibited full renal, ocular, and auditory manifestations of AS (12) . The targeting construct pG5X is shown schematically in Figure 1 . Short and long arms of homology were amplified by PCR from 129/SvJ mouse genomic DNA on the basis of available sequence (GenBank accession NT_085818.1), and cloned, with loxP sites, adjacent to a neomycin-resistance cassette (neo R ). The point mutation was introduced by site-directed mutagenesis into codon 5, conserved in mouse Col4a5.
The targeting construct was introduced via electroporation into mouse embryonic stem cells, and stable clones were selected in G418-containing media. Four positive clones were identified by PCR and Southern blotting, among which two harbored the point mutation. One clone, injected into C57BL/6 blastocysts, produced 14 high-coat color chimeras, 11 male and 3 female, that reached reproductive age. Three male chimeras transmitted the mutant allele to female offspring. Female carriers selected from among these first-generation offspring were mated with males from the FVB/N-TgN(ACTB-cre)2Mrt strain (The Jackson Laboratories, Bar Harbor, ME), a "deletor" strain expressing Cre recombinase under the human ␤-actin promoter (13) , thus excising neo R . Germline transmission of the neo R -negative allele to succeeding generations was confirmed by genotyping. Both neo Rpositive and -negative lines have been generated by successive backcrosses onto the C57BL/6 background. Animal protocols were ap- Figure 1 . Targeting strategy and genotyping for the Col4a5 mutation. (A) Predicted alleles following homologous recombination in embryonic stem cells and Cre recombination in vivo are shown. Exons, neo R , and PCR genotyping primers (arrows) are indicated. In the Southern hybridization strategy, an external probe identifies the modified locus as an aberrant AflII (A) restriction fragment. (B) Allele-specific PCR. Amplicons of differing size are produced by allele-specific primers complementary at their 3'-end bases to the wild-type (ASP wt ; C) or mutant (ASP G5X ; T) base. Additional mismatches, determined experimentally for optimal single-tube reaction conditions, are in bold. *G5X mutation. (C) Genotyping from representative litters by Southern blotting and allelespecific PCR assays, using the primer set F1/ASP wt / ASP G5X /R1, or F2/R2. Characteristic patterns are shown for wild-type animals (Y/ϩ, ϩ/ϩ), mutant male mice (Y/Ϫ), and female carrier mice (ϩ/Ϫ).
proved by the Institutional Animal Care and Use Committee of the University of Minnesota.
Genotyping
Mouse embryonic stem cell and tail DNA was extracted using the Easy DNA Kit (Invitrogen, San Diego, CA). For Southern blotting, 5-g DNA samples were digested, separated on 0.8% agarose gels, and transferred to nylon membranes. Probes external to the arms of homology were prepared by 32 P-dCTP random labeling, and hybridization and subsequent washings were carried out by standard techniques. For PCR genotyping, we developed a single-tube, allelespecific assay, optimized for PCR conditions, and directed against the point mutation. In this assay, a set of four primers yields a 172-bp amplicon from the wild-type allele and a 248-bp amplicon from the mutant allele (Figure 1) . A second PCR genotyping assay was developed to detect the single remaining loxP site in mice from the neo R -negative line ( Figure 1 ). For this assay, primers were as follows: F2, 5'-TTTGTTTGTAGGTCCTTTCATACATC-3'; and R2, 5'-GTG-TATTTATTGATTGTATTGTGACTTGG-3'. Cycling conditions consisted of denaturation at 94°C for 30 s, followed by 28 cycles of denaturation at 94°C for 30 s, and combined annealing and polymerization at 68°C for 20 s. Products were resolved on 3.5% agarose gels.
Laboratory Analysis
Mice were anesthetized by intraperitoneal injection of pentobarbital (50 mg/kg). Blood and urine samples were obtained by puncture of the vena cava and bladder, respectively. Urine protein was measured using the Bio-Rad Protein Assay (Richmond, CA). Urine creatinine was measured by the Jaffé reaction, using the Creatinine Analyzer-2 (Beckman Coulter). Plasma urea nitrogen was measured using the Liquid Urea Nitrogen Reagent Set (Pointe Scientific).
Histology
Animals were anesthetized, and kidneys were perfused via the abdominal aorta with 1.25% glutaraldehyde solution before removal. For light microscopy, kidneys were embedded in paraffin, cut into sections, and stained with periodic acid-Schiff reagent, using standard techniques. For electron microscopy, 2-to 3-mm pieces of cortex fixed in 1.25% buffered glutaraldehyde solution were processed successively using the Automated Tissue Processor (EMS LYNX) and embedded in a premade Epon 812 resin mixture. Semithin sections were examined to identify glomeruli. Ultrathin sections on copper mesh grids were stained with uranyl acetate and lead citrate using the EM STAIN automatic grid stainer (Leica, Wetzlar, Germany) and examined with a CX-100 transmission electron microscope (JEOL, Tokyo, Japan).
Immunofluorescence
Kidneys were removed, immersed in OCT, and snap-frozen in liquid nitrogen vapor. Five-micrometer cryostat sections were placed on slides and postfixed in acetone. Tissues were stained as described previously (14) . Epitope-defined rat monoclonal antibodies directed against the ␣1(IV) (H11), ␣2(IV) (H22), ␣3(IV) (H31), ␣5(IV) (H53), and ␣6(IV) (B66) chains were used for immunostaining (15) . Secondary FITC-conjugated donkey anti-rat IgG antibody was obtained from Jackson Immunoresearch (West Grove, PA). Slides were viewed by fluorescence microscopy.
Ribonuclease (RNase) Protection Assays
Riboprobe templates were amplified by PCR from a mouse kidney cDNA library (Clontech, Palo Alto, CA), and cloned into pBC KS-(Stratagene, La Jolla, CA). With corresponding GenBank accessions, nucleotide (nt) positions, and sizes, these were directed against messages for the ␣1(IV) (XM_134042, nt 3918 to 4311, 394 bases), ␣3(IV) (NM_007734, nt 5554 to 5850, 297 bases), ␣4(IV) (NM_129902, nt 4832 to 5050, 219 bases), and ␣5(IV) (XM_136081, nt 2101 to 2257, 157 bases) chains and L32 (NM_172086, nt 369 to 483, 115 bases). Templates were verified by direct sequencing. Riboprobes were synthesized by transcription of linearized template mixtures with T7 RNA polymerase (Ambion, Austin, TX). Total RNA was extracted from whole mouse kidney using Ultraspec RNA (Biotecx Laboratories). Twenty-microgram samples were subjected to assay using the RPAIII Kit (Ambion). Protected fragments were resolved by electrophoresis in denaturing 6% polyacrylamide gels. Gels were scanned by phosphorimaging (Molecular Dynamics, Sunnyvale, CA), and bands were quantified using ImageQuant (Molecular Diagnostics). Band densities were adjusted for the length of the probe and expressed relative to L32.
Statistical Analyses
Genotype distributions were compared with expectations from Mendelian ratios by 2 analysis. Survival curves for mutant male mice and female carrier mice were estimated by Kaplan-Meier productlimit estimates, censoring mice that were killed at predetermined time points. Curves were compared by the log-rank test. Message levels measured by RNase protection assay were compared by t test.
Results

Pedigrees
On the basis of a human mutation (12), we introduced the G5X nonsense mutation into the signal peptide sequence of the mouse Col4a5 gene. Results are presented for Col4a5-targeted mouse lines through the ninth generation of backcrossing onto the C57BL/6 background. Mutant male mice and female carrier mice were viable and fertile, with the ability to transmit the mutation to offspring. Genotyping assays for representative litters are shown in Figure 1 . Examination of the resultant pedigrees for the neo R -positive line and the neo R -negative line, generated by Cre recombinase-mediated excision of the neo R cassette, showed the expected Mendelian segregation ratio of 1:1:1:1 (Table 1) .
By immunofluorescence, we detected ␣1(IV), ␣2(IV), ␣3(IV), and ␣5(IV) chain expression within glomerular and tubular basement membranes of wild-type kidneys (Figure 2 ), consistent with previously described patterns (16) . Expression of the ␣5(IV) chain was lost in kidneys from mutant male mice, confirming predicted effects of the targeted mutation. Basement membrane expression of the ␣3(IV) chain was also lost, whereas that of the ␣1(IV) and ␣2(IV) chains was conserved. Expression of the ␣6(IV) chain, detected within Bowman's capsule in wild-type mice, was lost (not shown). Expression of the ␣5(IV) and ␣3(IV) chains in kidneys from female carriers was mosaic, reflecting X-inactivation. Effects of the targeted mutation on type IV collagen expression were similar in the neo R -positive and -negative lines and were con-sistent with those of spontaneously occurring XLAS mutations in humans and dogs (17) .
Clinical Course of Col4a5-Targeted Mice
There were no obvious differences in clinical or pathologic course between the neo R -positive and -negative lines; therefore, the lines were combined for further analysis.
All animals
Mutant male mice and female carrier mice developed progressive functional and histologic abnormalities of the kidneys, likely the major cause of death. Proteinuria, defined arbitrarily as urine protein excretion Ͼ10 mg/mg creatinine, was rarely observed in wild-type mice. By contrast, 97% of mutant male mice that were examined after 7 wk of age (n ϭ 63) and 78% of female carrier mice that were examined after 9 wk of age (n ϭ 50) had proteinuria (Figure 4) . Plasma urea nitrogen measurements also segregated mutant male mice and female carrier mice from wild-type littermates, by inspection ( Figure 5 ).
Pathologic Findings in Col4a5-Targeted Mice
Kidneys from mutant male mice and female carrier mice were grossly abnormal at end stage, exhibiting surface pallor, dullness, and pockmarking (not shown). By light microscopy, 2 ϭ 2.14, P ϭ 0.14.
Figure 2. Immunostaining for type IV collagen chains in kidneys of wild-type male mice (A, D, G, and J), mutant male mice (B, E, H, and K), and female carrier mice (C, F, I, and L). Expression of the ␣1(IV)
(A, B, C) and ␣2(IV) (D, E, F) chains was conserved in mutant male mice and female carrier mice. Expression of the ␣3(IV) (G, H, I) and ␣5(IV) (J, K, L) chains was present in wild-type male mice, absent in mutant male mice, and present in a mosaic pattern in female carrier mice. Figure 3 . Estimated survival functions for mutant male mice and female carrier mice.
we observed progressive pathologic changes ( Figure 6 ). Kidneys from mutant male mice at 4 wk of age displayed only subtle pathologic findings of capillary wall thickening and mesangial hypercellularity, with overall sparing of the tubulointerstitium. By 17 wk of age, widespread interstitial inflammation with tubular atrophy and dilation was present. At this stage, glomeruli exhibited variable and manifold abnormalities, including capillary loop dilation and simplification, capillary tuft collapse, capsular adhesions, and focal sclerosis. Rarely, crescents were present. Kidneys from female carrier mice also demonstrated progression of pathologic abnormalities, over an extended time scale, by comparison. Kidney sections from a female carrier at 17 wk of age revealed focal abnormalities of the glomeruli and tubulointerstitium ( Figure  6 ). Lamellation of glomerular basement membranes, a hallmark ultrastructural feature of AS, was evident in kidney sections from mutant male mice as young as 4 wk (Figure 7 ). By 17 wk of age, diffuse glomerular basement membrane abnormalities, including lamellation and splitting, were fully evident. Concomitant evidence of podocyte injury included foot process effacement, vesiculation, and denudation. Study of a female carrier at 17 wk of age revealed focal areas of lamellation within some glomeruli and more diffuse changes within others (Figure 7 ). Study of a female carriers at 30 wk of age revealed widespread changes (not shown).
Effects of the Col4a5 Mutation on Type IV Collagen mRNA Levels
To begin addressing detailed mechanisms of the nonsense mutation, we measured type IV collagen chain mRNA levels in kidneys from weanling mice of the neo R -negative line. Levels for ␣1(IV), ␣3(IV), and ␣4(IV) chain mRNA were not significantly different between wild-type and mutant male mice (Figure 8 ). The ␣5(IV) mRNA level, however, was significantly lower in mutant male mice, suggesting effects of the mutation on RNA synthesis and/or degradation.
Discussion
This is, to our knowledge, the first reported mouse model of XLAS. The clinical, histologic, and immunofluorescence findings described in this model closely approximate findings in human XLAS (9) . Affected male mice develop a progressive glomerulopathy manifested clinically by proteinuria and azotemia, leading to death from kidney failure at a young age. Indeed, their clinical course is comparable to those in previously described models of autosomal AS, rendered deficient in the type IV collagen minor chains by mutagenesis of the Col4a3-Col4a4 locus (18 -20) . Female carriers in our model of XLAS display dominant effects of the targeted mutation, with significant kidney abnormalities within 1 yr of age.
Several animal models of AS have been described (21) . Two spontaneous X-linked canine lines have been characterized: the Canadian Samoyed (22) and Navasota mongrel (23) lines. Affected male dogs develop proteinuria within the first 6 mo of life and progress to renal failure and death between 12 and 18 mo. Female carriers display proteinuria at 2 to 3 mo but progress comparatively slowly, with only a minority progressing to renal ESKD (24) . A spontaneous autosomal recessive inherited nephropathy was discovered in an English Cocker Spaniel line (14) . Several transgenic mouse models that follow an autosomal recessive inheritance pattern have been created. Two models were created by knockout of the Col4a3 gene (18, 19) , and a third was created by random insertional mutagenesis of the Col4a3 and Col4a4 genes (20) . A spontaneous bull terrier canine model is the only candidate autosomal dominant model of AS (25) . These models recapitulate clinical features of AS, with some variability. They have proved valuable in ongoing efforts to understand disease pathways (26 -31) and develop therapies (28, (31) (32) (33) (34) .
As a novel mouse model of the XLAS, our Col4a5-targeted lines should provide new opportunities for elucidating disease mechanisms. In particular, they afford a new model of the female carrier state, characterized by mosaic patterns of basement membrane type IV collagen expression. Determinants of disease progression in human XLAS carriers are largely unknown and likely to differ from those in male counterparts.
Whereas males who share familial mutations tend to progress to ESKD over comparable time frames, female carriers display significantly greater intrafamilial variability (35) . Furthermore, whereas genotype-phenotype correlations can be drawn in large cohorts of males, no such correlations can be drawn in comparable studies of female carriers (10) . It has been postulated that X-chromosome inactivation patterns, with their influence over type IV collagen expression, figure prominently in determination of the carrier phenotype, but studies have been few and limited primarily to assessments of extrarenal tissues (36) . This mouse model is uniquely suited for study of this and other clinical questions in the carrier female. It offers the possibilities of assaying kidney-wide X-inactivation patterns and basement membrane type IV collagen gene expression, as postulated determinants of disease severity, and of skewing X-inactivation experimentally, by breeding strategies, in directed investigations.
This report summarizes our findings for Col4a5-targeted lines through nine generations of backcrossing onto the C57BL/6 background. The experimental groups are on comparable but mixed genetic backgrounds. We fully expect that modified clinical and pathologic features of the model will become evident with progressive backcrossing to a congenic background. Indeed, the importance of genetic background, as a basis for phenotypic variability, has been established for an autosomal recessive Alport mouse line (26) .
Mutant mice in our lines transmit a known human point mutation. This "knock-in" mutation typifies "small" mutations, including substitutions, deletions, and insertions, composing the majority of XLAS mutations, now Ͼ300 in number. As such, the mutant line may offer options for tailoring novel therapies to knowledge of the specific disease mutation. For the G5X mutation, these options might include nonsense suppression, e.g., using aminoglycosides (37, 38) gene correction, using short gene fragments (39) . We have identified effects of the nonsense mutation on mRNA turnover, producing reduced levels of steady-state mRNA in weanling animals. It is likely that tailored therapies will have to account for this effect, which is lesser in magnitude than that observed in Samoyed dogs with XLAS as a result of a premature stop codon (40) but still significant. In contrast to findings in the Samoyed dog model, we did not observe coordinate changes in ␣3(IV) and ␣4(IV) mRNA levels.
In summary, we have described a novel mouse model of XLAS. This model should prove valuable in further elucidating primary basement membrane abnormalities and their promulgation through cellular elements within the kidney glomerulus and perhaps other tissue structures as well. The model should have special relevance in determining requirements for the type IV collagen chains in sustaining kidney function in female carrier mosaics. Finally, the model can serve as a tool in developing therapies, including but not limited to tailored counteraction of specific disease mutations, preservation of glomerular basement membrane performance, and prevention and treatment of secondary tubulointerstitial injury.
